Page last updated: 2024-10-28

haloperidol and Dental Enamel Hypoplasia

haloperidol has been researched along with Dental Enamel Hypoplasia in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Dental Enamel Hypoplasia: An acquired or hereditary condition due to deficiency in the formation of tooth enamel (AMELOGENESIS). It is usually characterized by defective, thin, or malformed DENTAL ENAMEL. Risk factors for enamel hypoplasia include gene mutations, nutritional deficiencies, diseases, and environmental factors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Acosta, E1
Cortes, O1
Guzman, S1
Catala, M1
Lorente, M1
Arense, JJ1

Other Studies

1 other study available for haloperidol and Dental Enamel Hypoplasia

ArticleYear
Relationship between molar incisor hypomineralization, intrapartium medication and illnesses in the first year of life.
    Scientific reports, 2022, 01-31, Volume: 12, Issue:1

    Topics: Administration, Intravaginal; Analgesics, Opioid; Anti-Bacterial Agents; Child; Communicable Disease

2022